Articles

AXI-STS: A UK NCRI Sarcoma Clinical Studies Group Phase 2 Trial of Axitinib in Advanced STS

Safety Profile of Trabectedin in Patients with Advanced Soft-Tissue Sarcoma (STS) Who Relapsed after Chemotherapy: Global Expanded Access Program Data

Trabectedin Combined with Nivolumab in Advanced STS

Trabectedin in Patients with Advanced Soft-Tissue Sarcoma (STS) Who Are Unfit for Standard Chemotherapy

TRC105 (Endoglin Antibody) in Combination with Pazopanib in Patients with Advanced Angiosarcoma

Meta-Analysis of Pazopanib versus Other Antiangiogenic Tyrosine Kinase Inhibitors (TKIs) in Advanced STS

Pembrolizumab in Advanced Soft-Tissue Sarcomas (STS)

Trabectedin or Gemcitabine-Taxotere in Relapsed Uterine Leiomyosarcoma (U-LMS)

Phase 2 Study of Regorafenib in Patients with Metastatic STS (RESOUND)

Adjuvant Therapies in Major Histological Subtypes of Extremity Soft-Tissue Sarcoma (STS)

Page 114 of 147